US judge lets Eli Lilly continue ads for weight-loss drugs, rules against Novo Nordisk
NVO•A U.S. court allowed Eli Lilly to continue weight-loss drug advertisements that rival Novo Nordisk claimed were false and misleading.
1. Court allows ads
A U.S. court on Monday allowed Eli Lilly to continue weight-loss drug advertisements that rival Novo Nordisk claimed were false and misleading.
